SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-135401
Filing Date
2022-05-02
Accepted
2022-05-02 08:02:36
Documents
19
Period of Report
2022-04-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d212050d8k.htm   iXBRL 8-K 42237
2 EX-4.1 d212050dex41.htm EX-4.1 118838
3 EX-10.1 d212050dex101.htm EX-10.1 207090
4 EX-10.2 d212050dex102.htm EX-10.2 99395
5 EX-99.1 d212050dex991.htm EX-99.1 7485
6 EX-99.2 d212050dex992.htm EX-99.2 8530
10 GRAPHIC g212050g0430024700629.jpg GRAPHIC 4551
11 GRAPHIC g212050snap1.jpg GRAPHIC 4259
  Complete submission text file 0001193125-22-135401.txt   737846

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA tpst-20220426.xsd EX-101.SCH 2862
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE tpst-20220426_lab.xml EX-101.LAB 17994
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tpst-20220426_pre.xml EX-101.PRE 11265
13 EXTRACTED XBRL INSTANCE DOCUMENT d212050d8k_htm.xml XML 3416
Mailing Address 7000 SHORELINE COURT SUITE 275 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT SUITE 275 SOUTH SAN FRANCISCO CA 94080 415-798-8589
Tempest Therapeutics, Inc. (Filer) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35890 | Film No.: 22879476
SIC: 2834 Pharmaceutical Preparations